Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) SHZ

3.77

-0.02(-0.53%)

Updated at September 12 03:04PM

Currency In CNY

Valuation

Market Cap5.73B
Enterprise Value5.54B
P/E Ratio-22.78
PEG Ratio-0.23
Price/Sales Ratio6.48
Price/Book Ratio1.74
Enterprise/Revenue6.35
Enterprise/EBITDA-21.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.28
Operating Margin-0.29

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.08

Income Statement

Revenue1.14B
Revenue/Share0.58
Gross Profit313.65M
EBITDA-182.08M
Net Income-373.37M
Diluted EPS-0.18

Balance Sheet

Total Cash552.52M
Total Cash/Share0.27
Total Debt338.78M
Total Debt/Equity0.08
Current Ratio3.03
Book Value Per Share2.14

Price History

52-Week Change66.81
52-Week High4.83
52-Week Low2.12
Moving Average 50 Days3.85
Moving Average 200 Days3.13

Statistics

Average Volume87.74M
Shares Outstanding2.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor2:1
Last Split DateMay 10, 2016